The IL-19 expression was significantly higher in the CD group of patients (N=72) in comparison with non-IBD controls (P<0.01). IL-19 expression was not related with the disease phenotype as per Montreal L or B classification. This evidence concerns the gene IL19 and inflammatory bowel disease.